Shi J - Search Results

1

Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.

Saul JP, Schaffer MS, Karpawich PP, Erickson CC, Epstein MR, Melikian AP, Shi J, Karara AH, Cai B, Hinderling PH. Saul JP, et al. Among authors: shi j. J Clin Pharmacol. 2001 Jan;41(1):35-43. doi: 10.1177/00912700122009818. J Clin Pharmacol. 2001. PMID: 11144992 Clinical Trial.

2

Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects.

Barbey JT, Sale ME, Woosley RL, Shi J, Melikian AP, Hinderling PH. Barbey JT, et al. Among authors: shi j. Clin Pharmacol Ther. 1999 Jul;66(1):91-9. doi: 10.1016/S0009-9236(99)70058-5. Clin Pharmacol Ther. 1999. PMID: 10430114 Clinical Trial.

3

Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia.

Saul JP, Ross B, Schaffer MS, Beerman L, Melikian AP, Shi J, Williams J, Barbey JT, Jin J, Hinderling PH; Pediatric Sotalol Investigators. Saul JP, et al. Among authors: shi j. Clin Pharmacol Ther. 2001 Mar;69(3):145-57. doi: 10.1067/mcp.2001.113795. Clin Pharmacol Ther. 2001. PMID: 11240979 Free article. Clinical Trial.

4

Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia.

Shi J, Ludden TM, Melikian AP, Gastonguay MR, Hinderling PH. Shi J, et al. J Pharmacokinet Pharmacodyn. 2001 Dec;28(6):555-75. doi: 10.1023/a:1014412521191. J Pharmacokinet Pharmacodyn. 2001. PMID: 11999292 Clinical Trial.

5

Pharmacokinetics of sematilide in renal failure.

Shi J, Ripley E, Gehr TW, Sica DA, Dandekar KA, Hinderling PH. Shi J, et al. J Clin Pharmacol. 1996 Feb;36(2):131-43. doi: 10.1002/j.1552-4604.1996.tb04178.x. J Clin Pharmacol. 1996. PMID: 8852389 Clinical Trial.

6

Kinetics and dynamics of sematilide.

Shi J, Lasser T, Koziol T, Hinderling PH. Shi J, et al. Ther Drug Monit. 1995 Oct;17(5):437-44. doi: 10.1097/00007691-199510000-00001. Ther Drug Monit. 1995. PMID: 8585104 Clinical Trial.

7

Absolute bioavailability estimated from oral data.

Hinderling PH, Shi J. Hinderling PH, et al. Among authors: shi j. J Pharm Sci. 1995 Mar;84(3):385-6. doi: 10.1002/jps.2600840323. J Pharm Sci. 1995. PMID: 7616383 No abstract available.

8

Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.

Shi J, Montay G, Chapel S, Hardy P, Barrett JS, Sack M, Marbury T, Swan SK, Vargas R, Leclerc V, Leroy B, Bhargava VO. Shi J, et al. J Clin Pharmacol. 2004 Mar;44(3):234-44. doi: 10.1177/0091270003262952. J Clin Pharmacol. 2004. PMID: 14973302 Clinical Trial.

9

Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment.

Shi J, Chapel S, Montay G, Hardy P, Barrett JS, Sica D, Swan SK, Noveck R, Leroy B, Bhargava VO. Shi J, et al. Int J Clin Pharmacol Ther. 2005 Mar;43(3):123-33. doi: 10.5414/cpp43123. Int J Clin Pharmacol Ther. 2005. PMID: 15792396 Clinical Trial.

10

Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil.

Ling J, Shi J, Jiang Q, Jiao Z. Ling J, et al. Among authors: shi j. Eur J Clin Pharmacol. 2015 Jan;71(1):95-106. doi: 10.1007/s00228-014-1771-1. Epub 2014 Oct 21. Eur J Clin Pharmacol. 2015. PMID: 25327506 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,603 results

Search Page

Filters